Pacaldo, Ruby Jean .
HRN: 01-96-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2023
CEFUROXIME 500MG (TAB)
01/18/2023
01/25/2023
ORAL
500mg
BID
Perineal Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes